Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Cumulative volumetric analysis as a key criterion for the treatment of brain metastases.

Kim IK, Starke RM, McRae DA, Nasr NM, Caputy A, Cernica GD, Hong RL, Sherman JH.

J Clin Neurosci. 2017 May;39:142-146. doi: 10.1016/j.jocn.2016.12.006. Epub 2017 Jan 11.

PMID:
28089195
2.

Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.

Iorio-Morin C, Masson-Côté L, Ezahr Y, Blanchard J, Ebacher A, Mathieu D.

J Neurosurg. 2014 Dec;121 Suppl:69-74. doi: 10.3171/2014.7.GKS141488.

PMID:
25434939
3.

Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.

Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Watanabe S, Kasuya H.

J Neurosurg. 2014 Dec;121 Suppl:16-25. doi: 10.3171/2014.8.GKS141421.

PMID:
25434933
4.

Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.

Frakes JM, Figura NB, Ahmed KA, Juan TH, Patel N, Latifi K, Sarangkasiri S, Strom TJ, Chinnaiyan P, Rao NG, Etame AB.

J Neurosurg. 2015 Nov;123(5):1261-7. doi: 10.3171/2014.12.JNS141919. Epub 2015 Jul 3.

PMID:
26140482
5.

Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.

Hall MD, McGee JL, McGee MC, Hall KA, Neils DM, Klopfenstein JD, Elwood PW.

J Neurosurg. 2014 Dec;121 Suppl:84-90. doi: 10.3171/2014.7.GKS14972.

PMID:
25434941
6.

Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.

Sneed PK, Mendez J, Vemer-van den Hoek JG, Seymour ZA, Ma L, Molinaro AM, Fogh SE, Nakamura JL, McDermott MW.

J Neurosurg. 2015 Aug;123(2):373-86. doi: 10.3171/2014.10.JNS141610. Epub 2015 May 15.

PMID:
25978710
7.

Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.

Shultz DB, Modlin LA, Jayachandran P, Von Eyben R, Gibbs IC, Choi CYH, Chang SD, Harsh GR 4th, Li G, Adler JR, Hancock SL, Soltys SG.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):993-999. doi: 10.1016/j.ijrobp.2015.04.036. Epub 2015 Apr 28.

PMID:
26194677
8.

Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.

Koiso T, Yamamoto M, Kawabe T, Watanabe S, Sato Y, Higuchi Y, Yamamoto T, Matsumura A, Kasuya H.

J Neurosurg. 2016 Dec;125(Suppl 1):2-10.

PMID:
27903177
9.

Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.

Sanghvi SM, Lischalk JW, Cai L, Collins S, Nair M, Collins B, Unger K.

Radiat Oncol. 2017 Feb 28;12(1):43. doi: 10.1186/s13014-017-0774-3.

10.

Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.

Smith TR, Lall RR, Lall RR, Abecassis IJ, Arnaout OM, Marymont MH, Swanson KR, Chandler JP.

J Neurosurg. 2014 Oct;121(4):839-45. doi: 10.3171/2014.4.JNS13789. Epub 2014 May 23.

PMID:
24857242
11.

Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.

Ojerholm E, Lee JY, Thawani JP, Miller D, O'Rourke DM, Dorsey JF, Geiger GA, Nagda S, Kolker JD, Lustig RA, Alonso-Basanta M.

J Neurosurg. 2014 Dec;121 Suppl:75-83. doi: 10.3171/2014.6.GKS14708.

PMID:
25434940
12.

Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.

Hartford AC, Paravati AJ, Spire WJ, Li Z, Jarvis LA, Fadul CE, Rhodes CH, Erkmen K, Friedman J, Gladstone DJ, Hug EB, Roberts DW, Simmons NE.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):650-5. doi: 10.1016/j.ijrobp.2012.05.027. Epub 2012 Jul 12.

PMID:
22795806
13.

Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.

Grandhi R, Kondziolka D, Panczykowski D, Monaco EA 3rd, Kano H, Niranjan A, Flickinger JC, Lunsford LD.

J Neurosurg. 2012 Aug;117(2):237-45. doi: 10.3171/2012.4.JNS11870. Epub 2012 May 25.

PMID:
22631694
15.

Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.

Karlovits BJ, Quigley MR, Karlovits SM, Miller L, Johnson M, Gayou O, Fuhrer R.

Neurosurg Focus. 2009 Dec;27(6):E7. doi: 10.3171/2009.9.FOCUS09191.

PMID:
19951060
16.

Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of Lesions.

Ali MA, Hirshman BR, Wilson B, Carroll KT, Proudfoot JA, Goetsch SJ, Alksne JF, Ott K, Aiyama H, Nagano O, Carter BS, Fogarty G, Hong A, Serizawa T, Yamamoto M, Chen CC.

World Neurosurg. 2017 Nov;107:944-951.e1. doi: 10.1016/j.wneu.2017.07.062. Epub 2017 Jul 19.

17.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
18.

Treatment of Large Brain Metastases With Stereotactic Radiosurgery.

Zimmerman AL, Murphy ES, Suh JH, Vogelbaum MA, Barnett GH, Angelov L, Ahluwalia M, Reddy CA, Chao ST.

Technol Cancer Res Treat. 2016 Feb;15(1):186-95. doi: 10.1177/1533034614568097. Epub 2015 Jan 28.

PMID:
25633136
19.

The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.

Yomo S, Hayashi M.

J Neurooncol. 2013 Jul;113(3):459-65. doi: 10.1007/s11060-013-1138-y. Epub 2013 May 10.

PMID:
23661101
20.

Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.

Bian SX, Routman D, Liu J, Yang D, Groshen S, Zada G, Trakul N, Wong MK, Yu C, Chang EL.

J Neurosurg. 2016 Dec;125(Suppl 1):31-39.

PMID:
27903181

Supplemental Content

Support Center